(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthylamine hydrochloride is a chiral amine derivative with a tetrahydro-naphthalene core structure. It is a key synthetic intermediate in the production of the pharmaceutical agent Rotigotine. This compound is primarily used in the synthesis of Rotigotine, a non-ergoline dopamine agonist. Rotigotine is an active pharmaceutical ingredient (API) used in the treatment of Parkinson's disease and restless legs syndrome. The (S)-enantiomer is crucial for the biological activity of the final drug product. As a chiral intermediate, its synthesis and purification are critical steps in ensuring the enantiomeric purity of the final API. The compound is typically handled under controlled conditions in pharmaceutical manufacturing settings.